Related Experiment Video

Updated: Oct 8, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K

The role of Exosomal miRNAs in cancer

Chuanyun Li1, Tong Zhou2, Jing Chen1,3

  • 1Fengtai District, YouAn Hospital, Capital Medical University, NO. 8, Xitoutiao, Youanmen wai, Beijing, China.

Journal of Translational Medicine
|January 4, 2022
PubMed

Insights

Exosomal microRNAs (miRNAs) are key regulators in cancer, influencing immunity, growth, and drug resistance. Understanding their mechanisms offers new avenues for cancer diagnosis, prognosis, and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Exosomal microRNAs (miRNAs) play crucial roles in gene regulation and are dysregulated in human cancers.
  • These molecules influence cancer immunity, microenvironment, tumor growth, invasion, metastasis, angiogenesis, and drug resistance.

Purpose of the Study:

  • To review recent advances in cancer-derived exosomes, focusing on RNA sorting and delivery.
  • To discuss the role of exosomal miRNAs in intercellular communication and their impact on cancer progression.
  • To summarize the potential of exosomal miRNAs as diagnostic and prognostic markers and in predicting therapeutic resistance.

Main Methods:

  • Literature review of recent publications on cancer-derived exosomes and exosomal miRNAs.
  • Analysis of mechanisms for exosomal RNA sorting and release.
  • Discussion of the functional roles of exosomal miRNAs in cancer biology.

Main Results:

  • Exosomal miRNAs are involved in modulating cancer cell-to-cell communication.
  • These miRNAs significantly impact tumor growth, angiogenesis, metastasis, and other biological features.
  • Exosomal miRNAs show promise as biomarkers for cancer diagnosis, prognosis, and predicting treatment response.

Conclusions:

  • Investigating exosomal miRNA mechanisms is vital for cancer treatment and prevention.
  • Exosomes serve as critical vehicles for miRNA transport, influencing cancer development.
  • Exosomal miRNAs represent a promising frontier for novel cancer diagnostics and therapeutics.
Keywords:
CancerExosomeTreatment resistancemiRNAs

More Related Videos

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.3K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.5K